Theriva publishes VCN-01 pancreatic cancer trial data in journal
Theriva publishes VCN-01 pancreatic cancer trial data in journal Investing.com
1140 материалов по теме, собраны автоматически из проверенных источников
Theriva publishes VCN-01 pancreatic cancer trial data in journal Investing.com
Исследование не выявило связи между семаглутидом и раком поджелудочной железы Life4me+
Исследование не выявило связи между семаглутидом и раком поджелудочной железы Life4me+
Исследование не выявило связи между семаглутидом и раком поджелудочной железы Life4me+
Adding a virus to chemotherapy was linked to improved survival in a pancreatic cancer trial Stock Titan
Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine Yahoo! Finance Canada
Five Radiation Sessions Before Pancreatic Cancer Surgery Preserved Physical Function, but Survival Was Numerically Lower in Small Trial Medical Daily
The Future Of Cancer Research Depends On The People We Prepare Today – Train at NCI Oncodaily
ВОЗ опубликовала новое исследование о доле случаев рака, вызванных вирусами и бактериями. Vietnam.vn
Researchers from Mass General Brigham and the University of Cyprus have developed a mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC). The work is published in the…
S.C. advocates travel to Capitol Hill seeking more cancer research funding WRDW
Dr Pelster on the MAPKeeper 301 Trial Evaluating Atebimetinib in First-Line Metastatic Pancreatic Cancer OncLive
Каждый восьмой случай рака в мире связан с инфекциями — исследование ВОЗ noi.md
Каждый восьмой случай рака в мире связан с инфекциями — исследование ВОЗ noi.md
Research published today in Cell identifies three small subclusters of cells that drive pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less able to tolerate cancer treatment. The study, led by the University of Oklahoma, could help researchers develop treatments…